Julia Sidenius Johansen

Julia Sidenius Johansen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 10 out of 212Page size: 10
Sort by: Title
  1. Published

    A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC)

    Theile, S., Johansen, Julia Sidenius, Nielsen, Dorte Lisbet, Jensen, B. V., Hansen, C. P., Hasselby, Jane Preuss, Eiríksson, S. V. & Chen, I. M., 2022, In: Pharmaceutics. 14, 3, 509.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    A clinical study of circulating cellular and humoral biomarkers involved in bone regeneration following traumatic lesions.

    Gottlieb, H., Klausen, T. W., Olsen, Bo Sanderhoff, Lausten, G., Kastrup, J. & Johansen, Julia Sidenius, 2011, In: Stem Cells Research Journal. 1, 3, p. 1-10

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01)

    Rasmussen, L. S., Winther, S. B., Chen, I. M., Weber, B., Ventzel, L., Liposits, G., Johansen, Julia Sidenius, Detlefsen, S., Egendal, I., Shim, S., Christensen, S., Pfeiffer, P. & Ladekarl, M., 2023, In: BMC Cancer. 23, 1, 10 p., 552.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

    Axelsen, M. B., Eshed, I., Hørslev-Petersen, K., Stengaard-Pedersen, K., Hetland, M. L., Møller, J., Junker, P., Pødenphanth, J., Schlemmer, A., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Dam, M. Y., Hansen, I., Horn, H. C., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J. & 4 others, Krogh, N. S., Johansen, Julia Sidenius, Østergaard, Mikkel & OPERA study group, O. S. G., May 2015, In: Annals of the Rheumatic Diseases. 74, 5, p. 867-875 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors

    Pedersen, S. J., Sørensen, I. J., Garnero, P., Johansen, J. S., Madsen, O. R., Tvede, N., Hansen, M. S., Thamsborg, G., Andersen, L. S., Majgaard, O., Loft, A. G., Erlendsson, J., Asmussen, K., Jurik, A. G., Møller, J., Hasselquist, M., Mikkelsen, D., Skjødt, T., Lambert, R., Hansen, A. & 1 others, Østergaard, Mikkel, 2011, In: Annals of the Rheumatic Diseases. 70, 8, p. 1375-81 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Adalimumab added to Methotrexate and intra-articular glucocorticoid increases remission rates at one year in early, DMARD-naïve patients with rheumatoid arthritis - An investigator-initiated randomized, controlled, double-blinded study.

    Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Pødenphanth, J., Ellingsen, T., Ahlqvist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Jørgensen, A., Krintel, S. B., Raun, J., Ammizbøll, C. G., Johansen, Julia Sidenius, Østergaard, Mikkel & Stengaard-Pedersen, K., 2011, In: Arthritis & Rheumatism. 63, 10 (suppl.), p. S147 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  7. Published

    Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial

    Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Pødenphant, J., Ellingsen, T., Ahlquist, P., Lindegaard, H., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Horn, H. C., Ammitzbøll, C. G., Jørgensen, A., Krintel, S. B., Raun, J., Johansen, Julia Sidenius, Østergaard, Mikkel, Stengaard-Pedersen, K. & OPERA Study-Group, O. S., Apr 2014, In: Annals of the Rheumatic Diseases. 73, 4, p. 654-661 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Age-dependent differences in first-line chemotherapy in patients with metastatic colorectal cancer: the DISCO study

    Lund, C. M., Vistisen, K. K., Dehlendorff, C., Rønholt, Finn, Johansen, Julia Sidenius & Nielsen, D. L., 2018, In: Acta Oncologica. 57, 11, p. 1445-1454 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Antibody directed against human YKL-40 increases tumor volume in a human melanoma xenograft model in scid mice

    Salamon, J., Hoffmann, T., Elies, E., Peldschus, K., Johansen, Julia Sidenius, Lüers, G., Schumacher, U. & Wicklein, D., 2014, In: PLOS ONE. 9, 4, p. 1-16 16 p., e95822.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8–12 years of follow-up

    Abrahamsson, H., Jensen, B. V., Berven, L. L., Nielsen, D. L., Šaltytė Benth, J., Johansen, J. S., Larsen, F. O., Johansen, Julia Sidenius & Ree, A. H., Apr 2020, In: International Journal of Cancer. 146, 7, p. 2019-2026

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...22 Next

ID: 13762833